CRYβB2 enhances tumorigenesis through upregulation of nucleolin in triple negative breast cancerYu Yan, Vanessa F. Merino, Soonweng Cho et al.|Oncogene|2021Cited by 13
Homeoprotein DLX4 expression is increased in inflammatory breast cancer cases from an urban African-American populationJaehong Jeong, Jan Blancato, Tammey Naab et al.|Oncotarget|2018Cited by 2
CRYβB2 is a biomarker for poor prognosis and response to CDK4/6 inhibitors in breast cancerYu Yan, Vanessa F. Merino, Athira Narayan et al.|Research Square|2025Cited by 0